BamSEC and AlphaSense Join Forces
Learn More

Allurion Technologies Inc. – Material Contracts

OTC: ALURD    
Share price (8/6/26): $4.30    
Market cap (8/6/26): $4.302 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 19 pages July 21, 2026 Rtw Investments, LP 40 10th Avenue, Floor 7 New York, Ny 10014 United States Re: 3(a)(9) Exchange Agreement Ladies and Gentlemen
12/34/56
EX-10.1
from 8-K 11 pages To: Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants
12/34/56
EX-10.4
from 10-Q 7 pages 1. Assignment and Assumption
12/34/56
EX-10.3
from 8-K 40 pages Securities Purchase and Exchange Agreement by and Among Allurion Technologies, Inc., Rtw Innovation Master Fund Ltd., Rtw Biotech Opportunities Operating Ltd and Rtw Master Fund, Ltd. November 11, 2025
12/34/56
EX-10.2
from 8-K 22 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 45 pages Securities Purchase Agreement
12/34/56
EX-10.7
from 10-Q 2 pages Eighth Amendment to Lease Legacy Huron, LLC, Lessor and Allurion Technologies, Inc., Lessee
12/34/56
EX-10.1
from 8-K 20 pages Second Amendment to Note Purchase Agreement
12/34/56
EX-10.2
from 8-K 26 pages Article 1 Definitions
12/34/56
EX-10.1
from 8-K 44 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 59 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 19 pages Article 1 Definitions
12/34/56
EX-10.48
from S-1/A 40 pages Securities Purchase Agreement
12/34/56
EX-10.49
from S-1/A 20 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It (I) Is Not Material and (II) Is of the Type That the Registrant Treats as Confidential, the Disclosure of Which Would Likely Cause Competitive Harm to the Company. Omnibus Amendment
12/34/56
EX-10.48
from S-1/A 40 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 90 pages Revenue Interest Financing Agreement Among Allurion Technologies, LLC and Rtw Master Fund, Ltd., Rtw Innovation Master Fund, Ltd., and Rtw Biotech Opportunities Operating Ltd Dated as of October 30, 2024
12/34/56
EX-10.7
from 10-Q 3 pages 17 May 2024 Mr. Ojas Buch [***] Re: Conditional Offer of Employment With Allurion Technologies, Inc
12/34/56
EX-10.6
from 10-Q 4 pages Eighth Amendment to Lease
12/34/56
EX-10.1
from 8-K 21 pages Article 1 Definitions
12/34/56
EX-10.4
from 8-K 9 pages First Amendment to Note Purchase Agreement
12/34/56